BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Necrosis

Necrosis is the name given to accidental death of cells and living tissue. It begins with cell swelling, chromatin digestion, and disruption of the plasma membrane and organelle membranes. Late necrosis is characterized by extensive DNA hydrolysis, vacuolation of the endoplasmic reticulum, organelle breakdown, and cell lysis. The release of intracellular content after plasma membrane rupture is the cause of inflammation in necrosis. In contrast to apoptosis, cleanup of cell debris by phagocytes of the immune system is generally more difficult, as the disorderly death generally does not send cell signals which tell nearby phagocytes to engulf the dying cell. This lack of signaling makes it harder for the immune system to locate and recycle dead cells which have died through necrosis than if the cell had undergone apoptosis. (From the Wikpedia article Necrosis.)

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Necrosis:

Pubmed Logo
Long catheter sign - a reliable bedside sign of incorrect positioning of Foley catheter in male spinal cord injury patients: a case report.
ABSTRACT: INTRODUCTION: Indwelling urethral catheter is often used in male...
19th July, 2008
Cases J. 2008 Jul 17;1(1):43.
DOI Direct Link
Are Prophylactic Antibiotics Really Ineffective in Reducing the Risk of Pancreatic Necrosis?
The serum cytokine levels (in particular interleukine-6 (IL-6) and tumour...
19th July, 2008
Department of Gastroenterology, and Hepatology, Kyoto University, Graduate Am J Gastroenterol. 2008 Jun 30;.
DOI Direct Link
CD43 controls the intracellular growth of Mycobacterium tuberculosis through the induction of TNF-alpha-mediated apoptosis.
Establishment of Tuberculosis infection begins with the successful entry...
19th July, 2008
Department of Medicine, University of British Columbia, Canada. Cell Microbiol. 2008 Jul 9;.
DOI Direct Link
Spontaneous In Vitro Transformation of Adult Neural Precursors into Stem-Like Cancer Cells.
Recent studies have found that cellular self-renewal capacity in brain...
19th July, 2008
Department of Neuropathology, Franz-Penzoldt-Center, University of Brain Pathol. 2008 Jul 10;.
DOI Direct Link
Isolation and Characterization of Immunostimulatory Polysaccharide from an Herb Tea, Gynostemma pentaphyllum Makino.
Water-soluble polysaccharide from Gynostemma pentaphyllum herb tea (PSGP)...
19th July, 2008
J Agric Food Chem. 2008 Jul 18;.
DOI Direct Link

View more research publications.

BioNews Results for Necrosis:

RSS Logo
BioPortfolio Logo
Arthritis wonder drugs may hold key for many more diseases
NetIndia123.com:  Jul 19 2008 1:51AM Matching: necrosis
Could arthritis wonder drugs provide clues for all disease?
Innovations Report:  Jul 18 2008 10:49PM Matching: necrosis
Arthritis wonder drugs may hold key for many more diseases
KeralaNext.com:  Jul 18 2008 9:58PM Matching: necrosis
Could arthritis wonder drugs provide clues for all disease?
Huliq.com:  Jul 18 2008 6:10PM Matching: necrosis
Arthritis wonder drugs may hold key for many more diseases
Webindia123:  Jul 18 2008 5:52PM Matching: necrosis
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Necrosis Clinical Trials:

Clinical Trials Logo
A Study to Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-Alpha (Tumor Necrosis Factor) in HIV-Infected Patients
HIV Infections

Necrosis Patents:

USPTO Logo
US Patent No.Title
7396906 Pro4399 Polypeptides
7399593 Member of the TNF ligand family
7399606 Methods for identifying I.kappa.B Kinase (IKK) inhibitors
7399613 Sialic acid nucleotide sugars
7399619 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination

View more patents.

Companies working in the area of Necrosis from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

GenVec

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent...
www.genvec.com/        View full profile
Thumbshot

Techniclone International Corporation

TECHNICLONE CORPORATION is engaged in the research and development of unique therapeutics for the treatment of cancer: The company utilizes innovative targeting technologies to develop products...
www.techniclone.com/        View full profile
Thumbshot

ENBREL

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as...
www.enbrel.com/        View full profile
Thumbshot

View more Necrosis related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Necrosis scientists - we have details of around 19087 individuals working on Necrosis .


This page has been viewed 108 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Necrosis across BioPortfolio, or bestselling Necrosis books or recently published Necrosis books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional